4D-710 in Adult Patients With Cystic Fibrosis
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Jonathan Singer, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Jonathan Singer, MD
Dr. Jonathan Singer is a Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. He specializes in the care of adults with advanced lung disease and lung transplant recipients.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- 4D Molecular Therapeutics
- ID
- NCT05248230
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 40 study participants
- Last Updated